Anne‐Marie Mes‐Masson

ORCID: 0000-0002-6498-266X · 4 papers in corpus · active 2010-2015

Study types

  • article 4

Condition tags

  • endometriosis 3
article 2015
The ARID1A pathway in ovarian clear cell and endometrioid carcinoma, contiguous endometriosis, and benign endometriosis
International Journal of Gynecology & Obstetrics ·doi:10.1016/j.ijgo.2015.02.021

OBJECTIVE: To assess ARID1A-encoded protein (BAF250a) and phosphorylated AKT (pAKT) expression, apoptosis, and the DNA damage response pathway in endometrioid and clear cell ovarian cancers (endometriosis-associated ovarian cancers [EAOCs])…

article 2012
Combination of Serum Biomarkers to Differentiate Malignant From Benign Ovarian Tumours
·doi:10.1016/s1701-2163(16)35273-2
article 2010
Authors' Reply
·doi:10.1002/path.2740

We are pleased to respond to the interesting comments of Dr Stewart concerning the molecular subtyping of ovarian endometrioid carcinomas. We recently published a study on epithelial ovarian cancer in which we concluded that a number of hig…

article 2010
ARID1A Mutations in Endometriosis-Associated Ovarian Carcinomas
The New England journal of medicine ·doi:10.1056/nejmoa1008433

BACKGROUND: Ovarian clear-cell and endometrioid carcinomas may arise from endometriosis, but the molecular events involved in this transformation have not been described. METHODS: We sequenced the whole transcriptomes of 18 ovarian clear-ce…